11 – 20 of 22
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Loss of Dystrophin and β-Sarcoglycan, Respectively, Significantly Exacerbates the Phenotype of Laminin α2 Chain-Deficient Animals.
(
- Contribution to journal › Article
- 2011
-
Mark
Transgenic Expression of Laminin α1 Chain Does Not Prevent Muscle Disease in the mdx Mouse Model for Duchenne Muscular Dystrophy.
(
- Contribution to journal › Article
-
Mark
Autophagy is increased in laminin {alpha}2 chain-deficient muscle and its inhibition improves muscle morphology in a mouse model of MDC1A.
(
- Contribution to journal › Article
-
Mark
Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies.
(
- Contribution to journal › Article
- 2010
-
Mark
Transgenic overexpression of laminin 1 chain in laminin 2 chain-deficient mice rescues the disease throughout the lifespan
(
- Contribution to journal › Article
-
Mark
Distinct roles for laminin globular domains in laminin alpha1 chain mediated rescue of murine laminin alpha2 chain deficiency.
(
- Contribution to journal › Article
- 2009
-
Mark
Substantial improvement of laminin alpha 2 chain deficiency by laminin alpha 1 chain overexpression persists throughout life
2009) 14th International Congress of the World-Muscle-Society In Neuromuscular Disorders 19(8-9). p.618-618(
- Contribution to journal › Published meeting abstract
- 2007
-
Mark
Dystroglycan: a possible mediator for reducing congenital muscular dystrophy?
(
- Contribution to journal › Scientific review
- 2006
-
Mark
Laminin {alpha}1 chain improves laminin {alpha}2 chain deficient peripheral neuropathy.
(
- Contribution to journal › Article
-
Mark
Laminin alpha1 chain mediated reduction of laminin alpha2 chain deficient muscular dystrophy involves integrin alpha7beta1 and dystroglycan.
(
- Contribution to journal › Article